Clinical Trial Update: Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP) [Phase 2]

View source ↗

Summary

Phase II trial evaluating the efficacy and safety of Nemonoxacin Malate for treating adults with community-acquired pneumonia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Nemonoxacin Malate (nemonoxacin)

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Community-acquired Pneumonia | Phase 2 | Status: COMPLETED